Here's what to know about smishing scams, which involve fake text messages baiting to get personal information and access ...

A real estate scam is overwhelming county deed offices across Maine, leaving landowners scrambling to prove what's rightfully ...

In January, the FTC flagged a smishing scam: a message that appears to be from a state road toll company that informs ...

Barnabas Jime took responsibility for his role, which authorities say involved others who actually posed as romantic ...

Shares in telehealth business Hims & Hers Health (HIMS) dropped over 6% today after reports that it and peers are marketing ...

That’s why, as a 2016 Vox investigation found, there are many reports of vitamins and supplements containing ingredients that ...

The move: Hims & Hers stock plunged by as much as 27% on Tuesday, hitting an intraday low of $37.29. The stock is down by 49% from its peak of $72.98 last week. The chart: Why: Hims & Hers said it ...

Hims and Hers' stock fell over 19% in after-hours trading on Monday after its CEO said the company would no longer sell compounded versions of mega-hit weight loss drugs. "We will have to start ...

Shares of Hims & Hers Health (NASDAQ:HIMS) continued to meltdown Tuesday in noontime trading after the direct-to-consumer healthcare platform said it couldn’t guarantee it would be able to ...

Hims & Hers Health Inc.’s stock plunged last week when the Food and Drug Administration said that there was no longer a shortage of the weight-loss drugs that allow for alternatives to be made.

Hims & Hers (HIMS) stock is sinking 20% today after Eli Lilly (LLY) unveiled significantly cheaper versions of its popular weight-loss drugs today. Additionally, the FDA last week hindered the ...